A critical care medicine specialist with Southeast University Zhongda Hospital returned to Nanjing on Thursday after fulfilling his anti-epidemic missions in northeast China’s Heilongjiang province and Jilin province and central China’s Hubei province.
Qiu Haibo, deputy CPC chief of Southeast University Zhongda Hospital, was assigned by the National Health Commission on January 19 to the front-line against the novel coronavirus pneumonia in Wuhan.
He was in charge of the diagnosis and treatment of the critically infected patients in Jinyintan Hospital, Wuhan Pulmonary Disease Hospital and Wuhan University Central South Hospital.
After fulfilling his anti-epidemic mission in Wuhan, Qiu was assigned on April 26 by the State Council to head for Mudanjiang city, Heilongjiang province, to supervise and instruct the treatment of COVID-19 patients.
On May 13 when the critically infected cases in Mudanjiang were cleared, Qiu Haibo was transferred to Jilin province to treat the COVID-19 patients there.
In the 139-day frontline work in Hubei, Heilongjiang and Jilin, Qiu applied the Jiangsu experience into the clinical treatment in the two provinces to ensure zero deaths for critical patients.
He was one of the top-notch experts who formulated the second to seventh editions of the diagnosis and treatment program of novel coronavirus infected pneumonia issued by the National Health Commission.
He was also the leader for the development of treatment plans for severe and critically ill COVID-19 patients.
